Colin Freund

Chief Executive Officer at Modra Pharmaceuticals BV

Colin Freund

Colin Freund

Chief Executive Officer at Modra Pharmaceuticals BV

Overview
Career Highlights

Modra Pharmaceuticals BV
QUE Oncology, Inc.

RelSci Relationships

123

Number of Boards

2

Birthday

1970

Age

49

Relationships
RelSci Relationships are individuals Colin Freund likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at Agennix, Inc.

Relationship likelihood: Strong

Senior Vice President-Human Resources & Corporate Integration at Agennix AG

Relationship likelihood: Strong

Chief Operating Officer & General Counsel at ASET Therapeutics, Inc.

Relationship likelihood: Strong

Senior Vice President, Pharmaceutical Development at Agennix AG

Relationship likelihood: Strong

Chief Executive Officer at Transgene SA

Relationship likelihood: Strong

Vice President-Responsible Pharmacist, Quality & Deputy Chief Executive Officer, Member of the Management Committee at Transgene SA

Relationship likelihood: Strong

Vice President, Regulatory Affairs at Concert Pharmaceuticals, Inc.

Relationship likelihood: Strong

Director-Marketing, Alliance & Project Management at Transgene SA

Relationship likelihood: Strong

Director Général, ABL Europe at Advanced Bioscience Laboratories, Inc.

Relationship likelihood: Strong

Executive Vice President, Director of Research & Development, Member of the Management Committee at Transgene SA

Relationship likelihood: Strong

Paths to Colin Freund
Potential Connections via
Relationship Science
You
Colin Freund
Chief Executive Officer at Modra Pharmaceuticals BV
Education
Bachelor of Arts Degree in Economics & Management Studies

The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.

Masters in Business Administration

The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Career History
Chief Executive Officer
2018 - Current

Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands.

Chief Executive Officer
2017 - 2017

QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA.

Vice President, Business Development
2013 - 2015

Transgene SA is a biotechnology company, which engages in the research, development, and manufacture of immunotherapies for the treatment of cancer and infectious diseases. Its products include TG4010, Pexa-Vec, TG4001, TG6002, TG1050, and TG4040. The company was founded in December 1979 and is headquartered in Strasbourg, France.

Boards & Committees
Member, Management Committee
Current

Transgene SA is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of immunotherapies for the treatment of cancer and infectious diseases. Its products include TG4001, TG6002, BT-001 and TG4050. The company was founded in December 1979 and is headquartered in Strasbourg, France.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Colin Freund. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Colin Freund's profile does not indicate a business or promotional relationship of any kind between RelSci and Colin Freund.